Metagenomi Reports Business Updates and Full Year 2023 : vim

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman...

Related Keywords

, Sarah Noonberg , Luis Borges , Pamela Wapnick , Ashlye Hodge , Simon Harnest , Brianc Thomas , Technology Platform , Nasdaq , Metagenomi Inc , Securities Exchange , Development Candidate , Chief Executive Officer , Program Highlights , Transthyretin Amyloidosis , Cardiovascular Disease , Technology Platform Highlights , Corporate Highlights , Nasdaq Global Select Market , Chief Medical Officer , Chief Scientific Officer , Chief Financial , Consolidated Statements , Ended December , Note Regarding Forward , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,